Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 26. Mai 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3010  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 60184  
   
Clinical profile and hepatocellular cancer treatment patterns in resource limited settings- a cross-sectional observational study at two tertiary referral teaching hospitals, Addis Ababa, Ethiopia.
BMC Gastroenterol
Hassen TJ, Nigussie S, Teshome H, Seife H.
PMID: 42185963 [PubMed - as supplied by publisher]


CR1(+) tumor-associated macrophages orchestrate an immunosuppressive niche in hepatocellular carcinoma: a genetic and multi-omics dissection.
J Transl Med
Wang Z, Wang Z, Ji X, Zhao L, Zheng K, Yu W, Zhang H, Chang H, Liu F.
PMID: 42185899 [PubMed - as supplied by publisher]


Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
J Gastroenterol
Shibuki T, Hoyek C, Ramaker R, Gottam M, Ueno M, Kawamoto Y, Itoh S, Inoue K, Hashimoto T, Fujisawa T, Imai M, Nakamura Y, Bando H, Pirozzi A, Zheng-Lin B, Abidoye O, Eslinger CR, Sonbol MB, Babiker H, Tran N, Morizane C, Strickler JH, Yoshino T, Bekaii-Saab T, Ikeda M.
PMID: 42185502 [PubMed - as supplied by publisher]


Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Nat Cancer
Perez KJ, Dias Costa A, Jordan A, Karasic TB, Elganainy D, Kim S, Yuan C, Gui DY, Tan R, Hong SC, Wang X, Cristea S, Coleman E, Truitt M, Oh TG, Zheng H, Furniss CS, Brais L, Bird A, Remland J, Gocheva V, Thalappillil JS, Anderson M, Cleary JM, Enzinger A, Giannakis M, Ng K, Rubinson DA, Schlechter B, Surana R, Singh H, Abrams T, Teitelbaum U, Izgur N, Allen E, Winter PS, Raghavan S, Yeh JJ, Von Hoff D, Liddle C, Downes M, Evans RM, O'Dwyer P, Aguirre A, Nowak JA, Wolpin BM.
PMID: 42185478 [PubMed - as supplied by publisher]


Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database.
J Gastrointest Cancer
Dickey EM, Blansfield J, Hoffman RL, Jiang JM, Amini N.
PMID: 42184090 [PubMed - indexed for MEDLINE]


Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns.
Transpl Int
Cillo U, Furlanetto A, Lanari J, Nieddu E, Rosso E, D'Amico FE, Bassi D, Gringeri E.
PMID: 42183187 [PubMed - indexed for MEDLINE]


Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer.
Front Pharmacol
Liu YW, Men XD, Di BR, Lei YL, Xiang L, Luo YH.
PMID: 42181887 [PubMed]


Case Report: When pancreatic cancer is not cancer: a rare case of pancreatic head paraganglioma with life-threatening delayed pseudoaneurysm bleeding.
Front Surg
Ozcan A, Gunes G, Aydog G, Akkurt G.
PMID: 42181541 [PubMed]


Ferroptosis-related lncRNA signature predicts prognosis and treatment response in colon cancer.
Transl Cancer Res
Wang T, Wang C, Lu Y, Zhong Y, Xue Y, Liu X, Chen E, Lv G.
PMID: 42180976 [PubMed]


Plasma fatty acid associated with risk of gastrointestinal cancer: a prospective cohort study from UK Biobank.
Transl Cancer Res
Song T, Hu S, Sun Y, Wu J, Wu Y, Li X.
PMID: 42180903 [PubMed]


Optimization of temporal phase in multi-phase contrast-enhanced MRI for gross tumor volume determination in pancreatic cancer radiotherapy.
Transl Cancer Res
Meng K, Guo Y, Yin Y, Su Y, Wang L, Wang R, Gong G.
PMID: 42180859 [PubMed]


Effect of polyunsaturated fatty acids supplementation on nutritional status in patients with pancreatic cancer: a systematic review and meta-analysis.
PeerJ
Liu G, Wu C, Yang X, Liu Z, Zhu Y, Yang T, Zhang J, Lin X.
PMID: 42180603 [PubMed - indexed for MEDLINE]


In vitro study of biologically synthesized MgO nanoparticles cytotoxicity in cancer cell lines.
3 Biotech
Shivappa P, Gaddigal AT, Ganeshkar MP, Mirjankar MR, Poojari PB, Huyilagola PV, Irannanavar KM, Irannanavar SV, Kamanavalli CM.
PMID: 42179919 [PubMed]


Beyond a passive coating: The cancer glycocalyx as a dynamic biophysical and immune interface.
Histol Histopathol
Tomita H.
PMID: 42178997 [PubMed - as supplied by publisher]


Adrenocortical Carcinoma in Peutz-Jeghers Syndrome With a Rare STK11 Pathogenic Germline Variant: A Case Report.
Cancer Rep (Hoboken)
Ishida T, Kandori S, Takahashi R, Nitta S, Shiga M, Nagumo Y, Kawahara T, Hoshi A, Negoro H, Mathis BJ, Sugita S, Matsubara D, Ishiguro T, Nakajima T, Nishiyama H.
PMID: 42178247 [PubMed - indexed for MEDLINE]


Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens.
J Gastroenterol
Umemoto K, Nakahara K, Ohike N, Satta Y, Sekine A, Igarashi Y, Nagata Y, Kubota Y, Takeda H, Horie Y, Arai H, Izawa N, Hiraki H, Norose T, Koike J, Matoba R, Nishizuka S, Tateishi K, Sunakawa Y.
PMID: 42177316 [PubMed - as supplied by publisher]


First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study.
Adv Ther
Ren Z, Liang T, Gu S, Gou H, Peng C, Pan Y, Song T, Su H, Cao K, Liang H, Ying J, Geng Z, Yu W, Zhao H, Bai Y, Hao C, Mao Y, Li W, Wang L, Li D, Wang W, Li N, Malhotra U, Qin S.
PMID: 42176183 [PubMed - as supplied by publisher]


Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.
J Gastroenterol Hepatol
Matono T, Tada T, Hiraoka A, Hirooka M, Nakamura Y, Yoshida O, Kariyama K, Nouso K, Tani J, Morishita A, Atsukawa M, Itokawa N, Okubo T, Arai T, Takaguchi K, Tsutsui A, Nagano T, Itobayashi E, Nishimura T, Fukunishi S, Enomoto H, Tsuji K, Tanaka K, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Koshiyama Y, Ogawa C, Hatanaka T, Kanayama Y, Kakizaki S, Kawata K, Noritake H, Naganuma A, Kosaka H, Matsui K, Kaibori M, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Okamura J, Komatsu S, Matsuura T, Nakamura S, Ueda Y, Kim SK, Ohama H, Tada F, Fukumoto T, Hiasa Y, Kudo M, Kumada T.
PMID: 42175630 [PubMed - as supplied by publisher]


Cause-specific mortality in a population-level cohort of pancreatic cancer patients following chemotherapy: A SEER-based study.
Medicine (Baltimore)
Gao Z, Bei L, Peng K.
PMID: 42175404 [PubMed - indexed for MEDLINE]


Comparing Weight Loss Prior to Pancreatic Cancer Diagnosis in Cases and Controls: A Systematic Review and Meta-Analysis.
Stud Health Technol Inform
Price CA, Mold F, de Lusignan S, Smith NAS, Winn M, Lemanska A.
PMID: 42174848 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 60184    Seite 1 von 3010  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1